The concept that ROS regulate gene expression appears to be generally accepted, particularly in regard to NF- κB activation by pro-inflammatory cytokines.
However, a 41.1%% complete cytoreduction was achieved in the radical surgery group, so we should always keep in mind that complete gross cytoreductions are generally accepted, particularly in patients with less bulky UAD or less aggressive bowel carcinomatosis [ 3].
Unlike metastatic relapse, it is generally accepted that, particularly in patients who have had breast-conserving surgery, locoregional relapse is potentially treatable and should be detected early (Clark et al, 1985; Recht et al, 1989; Fowble et al, 1990; Kurtz et al, 1990; Haffty et al, 1991; Dalberg et al, 1998).
It is now generally accepted that bovines, particularly water buffaloes, are the major reservoir for human infection in China as they are naturally infected with schistosomes and deposit more eggs into the environment than humans or any other animal host.
It is generally accepted that lungs, particularly when injured, are vulnerable to additional damage by both cyclic recruitment/derecruitment and overinflation.
It is generally accepted that these substrates are particularly susceptible to downregulation by CK2β, which in the case of other substrates is instead overcome by concomitant upregulation by the β-subunit, whose dual function was recognized early (35, 36).
Although it is generally accepted that steatotic livers are particularly vulnerable to hepatic IRI, results from animal experiments indicate that the mechanisms underlying IRI are different in nonsteatotic and steatotic livers [ 5].
Rodent models, particularly mice, are generally accepted and used as correlates of physiological and behavioral dispositions of humans.
The right to consent emerged through case law, and although there was no single law requiring individuals to give consent to medical treatment, by the late 1980s, it was generally accepted that informed consent was required, particularly for surgery.
It is now generally accepted that newer molecular mechanism-based therapeutics, particularly those in combination regimens, are more likely to eradicate malignant disease.
First, he ruled that tata is an exemplary trademark: "It is now generally accepted in most countries that well-known marks, particularly those surrounded by an aura of high repute, excellent quality and respectability, deserve wide protection".
